Today, millions of Brazilians live with Chronic Kidney Disease, often without realizing it. Because it is silent in its early stages, CKD can progress without obvious symptoms.
Medical evaluation and proper follow-up are essential to identify risk factors and guide renal health care.
Nephrospec™ is a non-invasive technology studied and evaluated in clinical trials for application in patients with Chronic Kidney Disease, as evaluated and indicated by a physician.
STEP 01
Do you identify with any of these factors?
If you identify with one or more of these factors, talk to your doctor about evaluating your kidney function.
STEP 02
Chronic Kidney Disease can progress silently, especially in the early stages. In some cases, certain signs may appear over time:
Attention: these signs are not specific to CKD and may be related to other conditions. Medical evaluation is essential for investigation and diagnosis.
Chronic Kidney Disease can progress silently. The identification of risk factors, the performance of tests, and medical monitoring are fundamental for kidney health care.
Chronic kidney disease can progress silently, especially in its early stages.
Changes in pressure, swelling, fatigue, and changes in urine may require medical evaluation.
These conditions are among the main factors associated with the risk of chronic kidney disease.
Medical evaluation and kidney function monitoring help guide care over time.
Discover the main aspects of Nephrospec™ technology and its method of application.
It uses externally applied low-intensity acoustic waves.
The procedure is performed non-invasively in the kidney region, according to the clinical protocol.
The technology has been studied for its potential effects related to kidney function and blood circulation.
A non-invasive technology developed to complement the care of patients with Chronic Kidney Disease.
External application, without cuts, needles, or anesthesia.
The procedure is performed in sessions, according to the clinical protocol and medical evaluation.
Technology developed for application in the kidney region and studied in contexts related to renal function.
The technology has been studied in clinical and preclinical research.
The prescription of Nephrospec™ must be made by a physician, according to the clinical evaluation, the stage of the disease, and the individual characteristics of each patient.
Access studies, protocols, scientific materials, and exclusive content for physicians.
Nephrospec™ is a non-invasive technology that uses low-intensity acoustic waves applied externally to the kidney region. The technology has been studied in clinical contexts related to Chronic Kidney Disease and should be used according to medical evaluation and indication.
No. Nephrospec™ is applied externally, without cuts, needles, or anesthesia. The procedure must be performed according to the clinical protocol and the evaluation of the responsible physician.
The studied protocol involves sessions carried out over a few weeks. The quantity and frequency must follow the adopted clinical protocol and the evaluation of the responsible physician.
No. Nephrospec™ does not replace medical follow-up or treatments already prescribed for Chronic Kidney Disease. Its use must be evaluated by a physician within the clinical context of each patient.
Nephrospec™ has been evaluated in clinical studies regarding the safety and tolerability of its application. Like any medical procedure, its use must occur after an individual patient evaluation and under the supervision of a physician.
The prescription must be made by a qualified physician, based on the diagnosis, the stage of Chronic Kidney Disease, associated clinical conditions, and the individual characteristics of each patient.
Have questions about the technology, availability, informative materials, or customer service channels? Get in touch with the team responsible for Nephrospec™ in Brazil.
